Carregant...
Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis
Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...
Guardat en:
| Publicat a: | Ann Am Thorac Soc |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Thoracic Society
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/ https://ncbi.nlm.nih.gov/pubmed/23802816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|